Hennion & Walsh Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
121,559
+18,954
+18% +$376K 0.07% 338
2026
Q1
$1.97M Buy
102,605
+33,638
+49% +$663K 0.07% 357
2025
Q4
$1.31M Buy
68,967
+43,615
+172% +$808K 0.05% 456
2025
Q3
$473K Buy
+25,352
New +$474K 0.02% 720

Other funds holding SBRA

Hennion & Walsh Asset Management's SBRA Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Sabra Healthcare REIT (SBRA) stake by 18% in Q2 2026, buying an estimated $376K and bringing the position to 121,559 shares worth $2.37M. The position accounts for 0.07% of the portfolio, ranked #338.

Hennion & Walsh Asset Management first reported a position in SBRA in Q3 2025 and has held it in 4 quarters since. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Hennion & Walsh Asset Management held 121,559 shares of Sabra Healthcare REIT worth $2.37M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 18,954 Sabra Healthcare REIT shares in Q2 2026, an estimated $376K.
  • Sabra Healthcare REIT made up 0.07% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #338 holding.
  • Hennion & Walsh Asset Management first reported a position in Sabra Healthcare REIT in Q3 2025 and has held it in 4 quarters since.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.